Literature DB >> 21086090

A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent protein-expressing human colon tumor.

Heiying Jin1, Zhijian Yang, Jiangdong Wang, Suying Zhang, Yu Sun, Yijiang Ding.   

Abstract

The orthotopic transplantation model of human tumor has been demonstrated to be more patient-like animal tumor model. However, observations of tumor progression and metastasis are limited by the deep location of the colon or limited deep penetration ability of fluorescence through tissue. The purpose of this study is to establish a superficial orthotopic model to allow easier real-time visualization and more sensitive monitoring of fluorescent orthotopic colon tumor. Human colon cancer HT-29 cells were transduced with a pLPCX expression retroviral vector containing green fluorescent protein and neomycin resistance genes. For superficial orthotopic transplantation model, the cecum was identified and pulled out of the peritoneal cavity, the space between the cecum and peritoneum was sutured, the cecum was pulled to subcutaneous tissue, and incision was made on the cecal serosa followed by the implantation of a 1-mm tumor tissue to the cecum. For comparison, a conventional orthotopic transplantation model was established in a separate group of mice simultaneously. When tumor sizes reached 5 mm in diameter, half the mice in each model received 5-FU treatment. Primary tumor and metastases were monitored by fluorescent imaging or caliber measurement. Tumor fluorescence was observed as early as 3 days (median time of 4.7 ± 1.3 days) post-transplantation in the superficial orthotopic transplantation model, which was much earlier than 21 days (median time of 26.2 ± 9.9 days) in conventional orthotopic transplantation model. Although tumor growth of 5-FU-treated mice in conventional orthotopic model was lower than those of the untreated mice, the difference was not significant. However, in superficial orthotopic model, tumor growth was significantly inhibited in 5-FU-treated mice relative to the untreated mice. Fluorescence imaging showed similar metastasis incidence between the superficial and conventional orthotopic transplantation models. The fluorescent superficial orthotopic transplantation colon model allows easier real-time visualization and more sensitive monitoring of tumor growth as well as convenient repeated sampling. It is a valuable orthotopic implantation model for study of colon cancer and evaluation of new anti-cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21086090     DOI: 10.1007/s13277-010-0132-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  12 in total

1.  Efficacy of new platinum analog DPPE in an orthotopic nude mouse model of human colon cancer.

Authors:  Y S Rho; K T Lee; J C Jung; C Yoon; Z An; R M Hoffman; S G Chang
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

Review 2.  Mouse models of gastrointestinal tumors.

Authors:  Makoto Mark Taketo
Journal:  Cancer Sci       Date:  2006-05       Impact factor: 6.716

Review 3.  Orthotopic is orthodox: why are orthotopic-transplant metastatic models different from all other models?

Authors:  R M Hoffman
Journal:  J Cell Biochem       Date:  1994-09       Impact factor: 4.429

4.  Whole-body imaging with fluorescent proteins.

Authors:  Robert M Hoffman; Meng Yang
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  A nude mouse model of massive liver and lymph node metastasis of human colon cancer.

Authors:  B Rashidi; F X Sun; P Jiang; Z An; R Gamagami; A R Moossa; R M Hoffman
Journal:  Anticancer Res       Date:  2000 Mar-Apr       Impact factor: 2.480

6.  Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.

Authors:  Robert M Hoffman
Journal:  Methods Mol Med       Date:  2005

7.  Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system.

Authors:  Kensuke Yamauchi; Meng Yang; Ping Jiang; Mingxu Xu; Norio Yamamoto; Hiroyuki Tsuchiya; Katsuro Tomita; Abdool R Moossa; Michael Bouvet; Robert M Hoffman
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

8.  The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer.

Authors:  Yong Ji; Katsuhiro Hayashi; Yasuyuki Amoh; Kazuhiko Tsuji; Kensuke Yamauchi; Norio Yamamoto; Hiroyuki Tsuchiya; Katsuro Tomita; Michael Bouvet; Robert M Hoffman
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

9.  A simple colostomy implantation model for evaluating colon cancer.

Authors:  Heiying Jin; Xiufang Liu; Vicky Ka Ming Li; Yijiang Ding; Shifeng Yun; Fei Liu; Senmei Zhou; Yong Song; Min Ni
Journal:  Int J Colorectal Dis       Date:  2008-09-05       Impact factor: 2.571

View more
  8 in total

1.  Development of a metastatic murine colon cancer model.

Authors:  Krista P Terracina; Tomoyoshi Aoyagi; Wei-Ching Huang; Masayuki Nagahashi; Akimitsu Yamada; Kazunori Aoki; Kazuaki Takabe
Journal:  J Surg Res       Date:  2015-04-15       Impact factor: 2.192

2.  Inhibitory effects of baicalin on orthotopic xenografts of colorectal cancer cells that are deficient in a mismatch repair gene in nude mice.

Authors:  Bo-Lin Yang; Hong-Jin Chen; Yu-Gen Chen; Yun-Fei Gu; Shu-Peng Zhang; Qiu Lin; Yu Sun
Journal:  Int J Colorectal Dis       Date:  2012-08-23       Impact factor: 2.571

3.  Evaluation of cloned cells, animal model, and ATRA sensitivity of human testicular yolk sac tumor.

Authors:  Junfeng Zhao; Congde Chen; Haochuan Zhang; Jinhui Shen; Hua Zhang; Xiaokun Lin; Le Qin; Xiaozhou Bao; Jie Lin; Wenqiang Lu; Xiangdong Wang; Xiaoming Chen
Journal:  J Transl Med       Date:  2012-03-13       Impact factor: 5.531

Review 4.  Mouse models of colorectal cancer as preclinical models.

Authors:  Rebecca E McIntyre; Simon J A Buczacki; Mark J Arends; David J Adams
Journal:  Bioessays       Date:  2015-06-26       Impact factor: 4.345

Review 5.  The role of mouse models in colorectal cancer research-The need and the importance of the orthotopic models.

Authors:  Rui C Oliveira; Ana Margarida Abrantes; José Guilherme Tralhão; Maria Filomena Botelho
Journal:  Animal Model Exp Med       Date:  2020-03-11

6.  Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling.

Authors:  Heiying Jin; Wei Gong; Chunxia Zhang; Shuiming Wang
Journal:  Onco Targets Ther       Date:  2013-03-08       Impact factor: 4.147

7.  Effect of onion flavonoids on colorectal cancer with hyperlipidemia: an in vivo study.

Authors:  Yongshan He; Heiying Jin; Wei Gong; Chunxia Zhang; Acheng Zhou
Journal:  Onco Targets Ther       Date:  2014-01-08       Impact factor: 4.147

8.  Generation of a cancer testis antigen mCherry reporter HCT116 colorectal carcinoma cell line.

Authors:  Jyoti B Chhetri; Elena Drousioti; José Afonso Guerra-Assunção; Javier Herrero; Steen K T Ooi
Journal:  Heliyon       Date:  2018-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.